Dhaka, Bangladesh (BBN) – The board of directors of IBN Sina Pharmaceuticals has recommended 12.50 per cent cash and 5.0 per cent stock as final dividend for the 6 months period from January 01, 2016 to June 30, 2016, said an official disclosure on Monday.
The total 37.50 per cent cash and 15 per cent stock dividend for 18 months period, including 25 per cent cash and 10 per cent stock, which was declared earlier for the period from January 01, 2015 to December 31, 2015, said the disclosure.
The final approval will come during the annual general meeting (AGM) scheduled to be held on November 26 at 9:30am in Dhaka.
The record date for entitlement of dividend is on October 24.
The company has reported earnings per share (EPS) of BDT 11.44, net operating cash flow per share (NOCFPS) of BDT 19.40 and net asset value (NAV) per share of BDT 38.72 for the 18 months period from Jan’15 – June’16 as against BDT 8.08, BDT 9.98 and BDT 26.89 respectively for the period from Jan’14 – June’15.
The company has also reported EPS of BDT 3.51, NOCFPS of BDT 9.80 and NAV per share of BDT 38.72 for the 6 months period from Jan-June, 2016 as against BDT 2.41, BDT 2.24 and BDT 26.89 respectively for the period from Jan-June, 2015.
There will be no price limit on the trading of the shares of the cmpany today following its corporate declaration.
The pharma and chemicals Sector Company’s share price closed at BDT 236.90 on Sunday.
The IBN Sina was listed on the Dhaka bourse in 1989. The company belongs to the “A” category.
The company’s paid-up capital is BDT 224.53 million and authorised capital is BDT 500 million while the total number of securities is 22,453,200, the DSE data showed.
The sponsor-directors own 43.87 percent stake in the IBN Sina, while the institutional investors 10.19 percent and the general public 45.94 percent as on August 31, 2016, the DSE data showed.